We are live on
!
Find out more
AB
Amalgamated Bank Portfolio holdings
AUM
$14.5B
1-Year Est. Return
44.3%
This Fund
S&P 500
This Quarter
Est. Return
+0.49%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$11.8B
AUM Growth
-$631M
(-5.1%)
Cap. Flow
-$566M
Cap. Flow
% of AUM
-4.78%
Top 10 Holdings %
Top 10 Hldgs %
19.95%
Holding
2,211
New
30
Increased
190
Reduced
1,934
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$20.2M |
| 2 |
Match Group
MTCH
|
+$6.61M |
| 3 |
Analog Devices
ADI
|
+$6.39M |
| 4 |
GXO Logistics
GXO
|
+$5.97M |
| 5 |
JHG
Janus Henderson
JHG
|
+$5.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$23.2M |
| 2 |
Microsoft
MSFT
|
+$23.2M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$11.6M |
| 4 |
Amazon
AMZN
|
+$11.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$9.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.59% |
| 2 | Financials | 14.53% |
| 3 | Healthcare | 13.01% |
| 4 | Consumer Discretionary | 12.03% |
| 5 | Industrials | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MORF
1976
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $210K | ﹤0.01% |
3,699
-216
| -6% | -$13.1K |
|
|
CONN
1977
DELISTED
Conn's Inc.
CONN
| $210K | ﹤0.01% |
9,220
-109
| -1% | -$2.59K |
|
|
CERE
1978
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $210K | ﹤0.01% |
+7,119
| New | +$200K |
|
1979
Stem
STEM
$50M
| $209K | ﹤0.01% |
438
-153
| -26% | -$80.5K |
|
1980
Seer Inc
SEER
$108M
| $208K | ﹤0.01% |
+6,031
| New | +$208K |
|
1981
National Presto Industries
NPK
$896M
| $207K | ﹤0.01% |
2,526
-31
| -1% | -$2.78K |
|
1982
Arcus Biosciences
RCUS
$3.5B
| $207K | ﹤0.01% |
+5,925
| New | +$184K |
|
|
MODN
1983
DELISTED
MODEL N, INC.
MODN
| $207K | ﹤0.01% |
6,189
-242
| -4% | -$8.18K |
|
1984
REX American Resources
REX
$1.44B
| $206K | ﹤0.01% |
15,492
-204
| -1% | -$2.76K |
|
1985
Super Micro Computer
SMCI
$19.3B
| $206K | ﹤0.01% |
56,460
-4,180
| -7% | -$15.2K |
|
1986
Anavex Life Sciences
AVXL
$232M
| $205K | ﹤0.01% |
11,435
-283
| -2% | -$5.63K |
|
1987
Sinclair Inc
SBGI
$974M
| $202K | ﹤0.01% |
6,362
-432
| -6% | -$12.7K |
|
|
LGF.B
1988
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $201K | ﹤0.01% |
15,443
-743
| -5% | -$9.77K |
|
1989
Atara Biotherapeutics
ATRA
$69.5M
| $200K | ﹤0.01% |
446
-32
| -7% | -$11.5K |
|
|
EVOP
1990
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $200K | ﹤0.01% |
8,451
-408
| -5% | -$10.8K |
|
1991
Orion
OEC
$379M
| $197K | ﹤0.01% |
10,816
-630
| -6% | -$11.3K |
|
|
CTEV
1992
Claritev Corp
CTEV
$372M
| $197K | ﹤0.01% |
875
-601
| -41% | -$163K |
|
1993
American Vanguard Corp
AVD
$75.2M
| $196K | ﹤0.01% |
13,032
-168
| -1% | -$2.66K |
|
|
WSR
1994
DELISTED
Whitestone REIT
WSR
| $195K | ﹤0.01% |
19,942
+162
| +0.8% | +$1.49K |
|
1995
Inovio Pharmaceuticals
INO
$79.4M
| $194K | ﹤0.01% |
2,254
-166
| -7% | -$16.7K |
|
|
DNMR
1996
DELISTED
Danimer Scientific, Inc.
DNMR
| $194K | ﹤0.01% |
298
-27
| -8% | -$19.9K |
|
|
AGEN
1997
Agenus
AGEN
$255M
| $193K | ﹤0.01% |
1,875
-22
| -1% | -$2.49K |
|
1998
Ezcorp Inc
EZPW
$1.87B
| $191K | ﹤0.01% |
25,231
-317
| -1% | -$2.04K |
|
1999
Oil States International
OIS
$512M
| $190K | ﹤0.01% |
29,723
-370
| -1% | -$2.23K |
|
2000
Opko Health
OPK
$936M
| $189K | ﹤0.01% |
51,894
-3,439
| -6% | -$12.8K |
|
Similar funds
JFG
IFP
BBVA
SSA
HIIFS
BGC
Amalgamated Bank's Q3 2021 Portfolio in Review
As of Q3 2021, Amalgamated Bank held 2,211 positions worth $11.8B, down 5.1% from $12.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Amalgamated Bank withdrew a net $566M in Q3 2021, closing 47 positions and reducing 1,934 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $11.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Amalgamated Bank opened a new position in GXO Logistics worth $5.97M.
- Amalgamated Bank's largest Q3 2021 buy was GXO Logistics: 76,088 shares worth $5.97M.
- Amalgamated Bank added most to Moderna in Q3 2021, an estimated $20.2M increase.
- Amalgamated Bank's biggest Q3 2021 reduction was Apple, cutting an estimated $23.2M.
- Amalgamated Bank fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $11.6M.
- Amalgamated Bank's ten largest holdings make up 20% of its $11.8B portfolio in Q3 2021.
- Amalgamated Bank opened 30 new positions and closed 47 in Q3 2021.
- Amalgamated Bank's portfolio value fell 5.1% quarter-over-quarter to $11.8B.
Based on Amalgamated Bank's 13F filing for Q3 2021, filed 29 Oct 2021.